Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity and Wyeth Expand Software Licensing Deal

NEW YORK, Feb. 3 (GenomeWeb News) - Wyeth Pharmaceuticals and Ingenuity Systems have expanded a license agreement between the companies pertaining to Ingenuity's Pathways Analysis software, the companies said today.

 

Wyeth's researchers "downstream in the pharmaceutical value chain" would gain access to the software, Ingenuity CEO Jake Leschly said in the statement.

 

Financial terms of the expanded agreement were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.